Walgreens (WBA) Insider Filing: Schlichting Gains 16,820 Shares

Rhea-AI Filing Summary

Nancy M. Schlichting, a director of Walgreens Boots Alliance, reported receiving an annual non-employee director share grant. The Form 4 shows she was issued 16,820 shares of WBA common stock on 08/13/2025 as director compensation under the company's 2021 Omnibus Incentive Plan, in arrears for services rendered the prior year. The grant price is recorded as $0, and the filing discloses that she now beneficially owns 37,961 shares. The form was signed on 08/15/2025 by an attorney-in-fact.

Positive

• Director alignment: Annual equity grant increases the reporting person's ownership to 37,961 shares, aligning interests with shareholders.
• Transparent disclosure: Transaction date (08/13/2025) and grant size (16,820 shares) are clearly reported on Form 4.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine director compensation grant increases insider ownership modestly; no cash purchase or disposition reported.

The Form 4 documents a standard annual equity grant to a non-employee director under the companys omnibus plan. The 16,820-share issuance is recorded at $0, consistent with equity-based compensation rather than an open-market purchase. Ownership rose to 37,961 shares, which marginally aligns the directors interests with shareholders. No dispositions, option exercises, or derivative positions are reported, and there are no indicators of material corporate actions or unusual insider timing in this filing.

Securities Analyst

TL;DR: Non-material insider grant reported; impact on share count and immediate market effect is likely negligible.

This disclosure reflects compensation in equity to a director for prior-year service. The grant increases reported beneficial ownership but does not involve cash proceeds or sales. From a market-impact perspective, the transaction is customary and unlikely to alter valuation or liquidity materially. The filing contains clear transactional details: grant date 08/13/2025, quantity 16,820 shares, and resulting beneficial ownership of 37,961 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SCHLICHTING NANCY M

(Last) (First) (Middle)

C/O WALGREENS BOOTS ALLIANCE, INC.

108 WILMOT ROAD

(Street)

DEERFIELD IL 60015

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Walgreens Boots Alliance, Inc. [ WBA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/13/2025		A(1)		16,820	A	$0	37,961	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Annual share grant issued as non-employee director compensation under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan in arrears with respect to services rendered over the course of the prior year.

Remarks:

	/s/ Nancy Schlichting by Paul Ingram, Attorney-in-Fact	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Nancy M. Schlichting report on the WBA Form 4?

She reported an annual non-employee director equity grant of 16,820 shares on 08/13/2025, increasing her beneficial ownership to 37,961 shares.

Was the WBA grant a purchase or a compensation award?

The grant is reported with a price of $0 and is described as director compensation under the companys 2021 Omnibus Incentive Plan.

Does the Form 4 show any sales or disposals by the reporting person?

No. The Form 4 shows an acquisition (grant) only; there are no dispositions or derivative transactions reported.

When was the Form 4 signed and who signed it?

The filing is signed on 08/15/2025 by Nancy Schlichting via attorney-in-fact Paul Ingram.

What plan governs the shares issued to the director?

The shares were issued under the Amended and Restated Walgreens Boots Alliance, Inc. 2021 Omnibus Incentive Plan as compensation in arrears for prior-year services.